Skip to main content
SpringerLink
Log in

Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T1 mapping

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

To evaluate long-term changes in diffuse myocardial fibrosis using cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) and T1 mapping. Patients with chronic stable cardiomyopathy and stable clinical status (n = 52) underwent repeat CMR at a 6 month or greater follow up interval and had LGE and left ventricular (LV) T1 mapping CMR. Diffuse myocardial fibrosis (excluding areas of focal myocardial scar) was assessed by post gadolinium myocardial T1 times. Mean baseline age of 52 patients (66 % male) was 35 ± 19 years with a mean interval between CMR examinations of 2.0 ± 0.8 years. CMR parameters, including LV mass and ejection fraction, showed no change at follow-up CMR (p > 0.05). LVT1 times (excluding focal scar) decreased over the study interval (from 468 ± 106 to 434 ± 82 ms, p = 0.049). 38 Patients had no visual LGE−, while 14 were LGE+. For LGE− patients, greater change in LV mass and end systolic volume index were associated with change in T1 time (β = −2.03 ms/g/m2, p = 0.035 and β = 2.1 ms/mL/m2, p = 0.029, respectively). For LGE+ patients, scar size was stable between CMR1 and CMR2 (10.7 ± 13.8 and 11.5 ± 13.9 g, respectively, p = 0.32). These results suggest that diffuse myocardial fibrosis, as assessed by T1 mapping, progresses over time in patients with chronic stable cardiomyopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB (2006) Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113(23):2733–2743. doi:10.1161/CIRCULATIONAHA.105.570648

    Article  PubMed  Google Scholar 

  2. Krittayaphong R, Saiviroonporn P, Boonyasirinant T, Udompunturak S (2011) Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion. J Cardiovasc Magn R 13. doi:10.1186/1532-429x-13-2

  3. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343(20):1445–1453. doi:10.1056/Nejm200011163432003

    Article  PubMed  CAS  Google Scholar 

  4. Chan W, Duffy SJ, White DA, Gao XM, Du XJ, Ellims AH, Dart AM, Taylor AJ (2012) Acute left ventricular remodeling following myocardial infarction coupling of regional healing with remote extracellular matrix expansion. Jacc Cardiovasc Imaging 5(9):884–893. doi:10.1016/j.jcmg.2012.03.015

    Article  PubMed  Google Scholar 

  5. Todiere G, Aquaro GD, Piaggi P, Formisano F, Barison A, Masci PG, Strata E, Bacigalupo L, Marzilli M, Pingitore A, Lombardi M (2012) Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 60(10):922–929. doi:10.1016/j.jacc.2012.03.076

    Article  PubMed  Google Scholar 

  6. Osorio J (2010) Molecular imaging: magnetic resonance angiography in pulmonary embolism diagnosis. Nat Rev Cardiol 7(6):302. doi:10.1038/nrcardio.2010.62

    Article  PubMed  Google Scholar 

  7. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57(8):891–903. doi:10.1016/j.jacc.2010.11.013

    Article  PubMed  Google Scholar 

  8. Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, Oh-I D, Klein C, Berger F, Kuehne T (2011) Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping. Circ Cardiovasc Imaging 4(6):636–640. doi:10.1161/CIRCIMAGING.111.966796

    Article  PubMed  Google Scholar 

  9. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52(19):1574–1580. doi:10.1016/j.jacc.2008.06.049

    Article  PubMed  Google Scholar 

  10. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, Mudd JO, van der Geest RJ, Lima JA, Halushka MK, Bluemke DA (2012) T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 265(3):724–732. doi:10.1148/radiol.12112721

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jellis C, Wright J, Kennedy D, Sacre J, Jenkins C, Haluska B, Martin J, Fenwick J, Marwick TH (2011) Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging 4(6):693–702. doi:10.1161/CIRCIMAGING.111.963587

    Article  PubMed  Google Scholar 

  12. Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, van der Geest RJ, Bonetti C, van der Velde ET, de Roos A, Smit JW, Leung DY, Bax JJ, Lamb HJ (2012) Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging 5(1):51–59. doi:10.1161/CIRCIMAGING.111.965608

    Article  PubMed  Google Scholar 

  13. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ (2012) Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn R 14. doi:10.1186/1532-429x-14-76

  14. Gai N, Turkbey EB, Nazarian S, van der Geest RJ, Liu CY, Lima JA, Bluemke DA (2011) T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med 65(5):1407–1415. doi:10.1002/mrm.22716

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nacif MS, Turkbey EB, Gai N, Nazarian S, van der Geest RJ, Noureldin RA, Sibley CT, Ugander M, Liu S, Arai AE, Lima JA, Bluemke DA (2011) Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J Magn Reson Imaging 34(6):1367–1373. doi:10.1002/jmri.22753

    Article  PubMed  PubMed Central  Google Scholar 

  16. Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, Hausenloy DJ, Ariti C, Yap J, Kolvekar S, Taylor AM, Moon JC (2012) Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 13(10):819–826. doi:10.1093/ehjci/jes102

    Article  PubMed  Google Scholar 

  17. Dall’Armellina E, Karia N, Lindsay AC, Karamitsos TD, Ferreira V, Robson MD, Kellman P, Francis JM, Forfar C, Prendergast BD, Banning AP, Channon KM, Kharbanda RK, Neubauer S, Choudhury RP (2011) Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index circulation. Cardiovasc Imaging 4(3):228–236. doi:10.1161/circimaging.111.963421

    Article  Google Scholar 

  18. Ichikawa Y, Sakuma H, Suzawa N, Kitagawa K, Makino K, Hirano T, Takeda K (2005) Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction: improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 45(6):901–909. doi:10.1016/j.jacc.2004.11.058

    Article  PubMed  Google Scholar 

  19. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE (2004) Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 43(12):2253–2259. doi:10.1016/j.jacc.2004.02.046

    Article  PubMed  Google Scholar 

  20. Chan W, Duffy SJ, White DA, Gao X-M, Du X-J, Ellims AH, Dart AM, Taylor AJ (2012) Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging 5(9):884–893. doi:10.1016/j.jcmg.2012.03.015

    Article  PubMed  Google Scholar 

  21. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7(1):30–37. doi:10.1038/nrcardio.2009.199

    Article  PubMed  Google Scholar 

  22. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Ubago JLM (2002) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105(21):2512–2517. doi:10.1161/01.Cir.000017264.66561.3d

    Article  PubMed  CAS  Google Scholar 

  23. Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Ubago JLM, Diez J (2001) Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 104(3):286–291

    Article  PubMed  CAS  Google Scholar 

  24. Ciulla MM, Paliotti R, Esposito A, Diez J, Lopez BA, Dahlof B, Nicholls G, Smith RD, Gilles L, Magrini F, Zanchetti A (2004) Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis–Results of a randomized trial. Circulation 110(5):552–557. doi:10.1161/01.Cir.0000137118.47943.5c

    Article  PubMed  CAS  Google Scholar 

  25. Liu CY, Liu YC, Wu C, Armstrong A, Volpe GJ, van der Geest RJ, Liu M, Hundley WG, Gomes A, Liu S, Nacif M, Bluemke DA, Lima JA (2013) Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 62(14):1280–1287. doi:10.1016/j.jacc.2013.05.078

  26. Yan AT, Coffey DM, Li Y, Chan WS, Shayne AJ, Luu TM, Skorstad RB, Khin MM, Brown KA, Lipton MJ, Kwong RY (2006) Images in cardiovascular medicine. Myocardial fibroma in gorlin syndrome by cardiac magnetic resonance imaging. Circulation 114(10): e376–379. doi:10.1161/CIRCULATIONAHA.105.605832

  27. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC (2007) Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115(15):2006–2014. doi:10.1161/CIRCULATIONAHA.106.653568

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O’Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896–908. doi:10.1001/jama.2013.1363

    Article  PubMed  CAS  Google Scholar 

  29. Holloway CJ, Betts TR, Neubauer S, Myerson SG (2010) Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. J Am Coll Cardiol 56(23):1961. doi:10.1016/j.jacc.2010.01.078

    Article  PubMed  Google Scholar 

  30. Pereira RS, Prato FS, Sykes J, Wisenberg G (1999) Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Magn Reson Med 42(1):60–68

    Article  PubMed  CAS  Google Scholar 

  31. Pereira RS, Prato FS, Wisenberg G, Sykes J (1996) The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 36(5):684–693

    Article  PubMed  CAS  Google Scholar 

  32. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ (2011) Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 57(7):821–828. doi:10.1016/j.jacc.2010.06.062

    Article  PubMed  Google Scholar 

  33. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26(4):1081–1086. doi:10.1002/Jmri.21119

    Article  PubMed  Google Scholar 

  34. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6(4):475–484. doi:10.1016/j.jcmg.2012.08.019

    Article  PubMed  Google Scholar 

  35. Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E (2013) Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 6(2):295–301. doi:10.1161/CIRCIMAGING.112.000151

    Article  PubMed  Google Scholar 

  36. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33(10):1268–1278. doi:10.1093/eurheartj/ehr481

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology and Imaging Sciences, National Institutes of Health, 10 Center Drive, Rm 10/1C355, Bethesda, MD, 20892, USA

    Colin J. Yi, Eunice Yang, Neville Gai, Chia Liu, Songtao Liu & David A. Bluemke

  2. Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Eunice Yang, Shenghan Lai, Stefan L. Zimmerman, João A. C. Lima & David A. Bluemke

Authors
  1. Colin J. Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eunice Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shenghan Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neville Gai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chia Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Songtao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefan L. Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. João A. C. Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David A. Bluemke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Bluemke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yi, C.J., Yang, E., Lai, S. et al. Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T1 mapping. Int J Cardiovasc Imaging 30, 1339–1346 (2014). https://doi.org/10.1007/s10554-014-0459-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-014-0459-z

Keywords

Search

Navigation